Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» OBD
OBD
Sucampo's Lubiprostone meets primary endpoint in Phase 3 clinical trial for OBD
Yahoo/Fly on the Wall
Thu, 02/2/12 - 10:08 am
Sucampo
Lubiprostone
OBD
opioid-induced bowel dysfunction